Liver resection of colorectal liver metastases in elderly patients. 2011

U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
Department of General-, Visceral- and Transplantation Surgery, Hannover Medical School, Hannover, Germany.

BACKGROUND The percentage of elderly patients with colorectal liver metastases (CLM) has increased. Liver resection remains the only curative therapy; data evaluating the outcome in this age group is limited. Aim of the present study was to determine if postoperative morbidity, mortality, and other independent predictors influence survival in patients ≥ 70 years undergoing liver resection for CLM. METHODS Clinical data on primary tumor and metastases of 939 patients after liver resection for CLM between 1994 and 2008 were retrospectively collected and subdivided in three age-groups (≥ 70, 40-69, <40). Independent predictors of survival were evaluated with overall and age-specific univariate and multivariate Cox regression models. RESULTS A total of 939 patients underwent liver resection for CLM, 20.3% aged ≥ 70 years. Overall postoperative mortality and morbidity were 1.08 and 14.82%, revealing no age-related differences. With 5-year survival of 31.8% in the elderly and 37.5% in the mid-age population, age ≥ 70 years was linked with decreased survival (Hazard Ratio [HR] = 1.305; P = 0.0186). Multivariate overall analyses showed size of CLM > 50 mm (HR = 1.376; P = 0.0060), a high amount of transfusion during surgery (HR = 1.676; P = 0.0110), duration of surgery >210 min (HR = 1.241; P = 0.0322), primary UICC (International Union Against Cancer) stage IV (HR = 2.297; P < 0.0001), and performance of repeat resections (HR = 0.652; P = 0.0107) as independent predictors of survival. In the elderly group, effects of UICC IV (HR = 3.260; P = 0.0148) and high numbers of transfusions (HR = 3.647; P = 0.0129) were confirmed; the others did not show statistical significance. CONCLUSIONS Resection of CLM at older age is feasible with morbidity and mortality rates similar to those in younger patients. Although age ≥ 70 was shown to be associated with poorer overall outcome, reasonable 5-year survival was observed.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
March 2010, The British journal of surgery,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
March 2019, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
August 2017, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
November 2004, Annals of surgery,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
December 1998, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
February 1994, Hepato-gastroenterology,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
September 2008, Critical reviews in oncology/hematology,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
October 2020, World journal of surgical oncology,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
April 2016, Journal of surgical oncology,
U Kulik, and T Framke, and A Grosshennig, and A Ceylan, and H Bektas, and J Klempnauer, and F Lehner
October 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland,
Copied contents to your clipboard!